May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Preventive Effect of Pyridoxal 5’–Phosphate on the Diabetic Retinopathy of Streptozotocin–Induced Diabetic Rat
Author Affiliations & Notes
  • H.G. Yu
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • S.–P. Park
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • K. Kim
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • Y. Kim
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • J.–M. Seo
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • K. Park
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
    Bundang Seoul National University Hospital, Seongnam, Republic of Korea
  • S. Kim
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • H. Chung
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  H.G. Yu, None; S. Park, None; K. Kim, None; Y. Kim, None; J. Seo, None; K. Park, None; S. Kim, None; H. Chung, None.
  • Footnotes
    Support  Korea Health 21 R&D Project MOHW 02–PJ1–PG1–CH02–0003
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 362. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H.G. Yu, S.–P. Park, K. Kim, Y. Kim, J.–M. Seo, K. Park, S. Kim, H. Chung; Preventive Effect of Pyridoxal 5’–Phosphate on the Diabetic Retinopathy of Streptozotocin–Induced Diabetic Rat . Invest. Ophthalmol. Vis. Sci. 2005;46(13):362.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Preventive effect of pyridoxal 5’–phosphate (PLP) on diabetic retinopathy was investigated in streptozotocin–induced diabetic rat model. Methods: Streptozotocin (70 mg/kg) was injected intraperitoneally to induce diabetes in 18 Sprague–Dawley male rats at the age of 7 weeks. Blood glucose level and the body weight were monitored as the indicator of the diabetic status of the rats. After one week of the streptozotocin injection, induced diabetes mellitus was certified by the blood glucose level. PLP is one of the active coenzyme in vitamin B6 family. On the basis of the proportion of body weight compared to human (1.5 mg / 60 kg), recommended therapeutic dose of PLP was calculated as 5 µg / 200 gm . PLP was injected intraperitoneally every two days after two weeks of streptozotocin injection, by 5 µg in normal dose group and by 50 µg in mega–dose group. In control group, normal saline was injected intraperitoneally. As a risk factor of vascular disease in diabetic state, blood homocysteine levels were measured after 3 weeks of PLP injections. Retinal vascular integrity was checked by fluorophotometer and the retinal ischemia was postulated by the expression of vascular endothelial growth factor (VEGF) in the retina. Results: Normal and mega–dose PLP group showed lower blood homocysteine level than that of the control group. Fluorophotometry showed less leakage of the fluorescein from the retinal vessels in normal and mega–dose group. VEGF was increased much more in the retina of control group than in the normal and mega–dose group. There were no differences between the normal and mega–dose group in all evaluation. There was no difference of the blood glucose level between the treatment group and control group. Conclusions: PLP seems to have inhibitory effect on the progression of early diabetic retinopathy without lowering blood glucose level.

Keywords: diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×